1. Centers of Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2017 2018.
http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf
. Accessed 30 Jun 2019.
2. Centers for Disease Control and Prevention. HIV Surveillance Report, 2017 2018.
http://cdc.gov/hiv/library/reports/hiv-surveillance.html
. Accessed 30 Jun 2019.
3. HIV.gov. National HIV/AIDS Strategy: Updated to 2020 2017.
https://www.hiv.gov/federal-response/national-hiv-aids-strategy/nhas-update
. Accessed 30 Jun 2019.
4. Centers for Disease Control and Prevention. HIV Basics: PrEP 2017.
http://www.cdc.gov/hiv/basics/prep.html
. Accessed 30 Jun 2019.
5. Bush S, Magnuson D, Rawlings MK, Hawkins T, McCallister S, Mera Giler R. Racial characteristics of FTC/TDF for pre-exposure prophylaxis (PrEP) users in the US. American Society for Microbiology 2016; 2016 June 16–20, 2016; Boston, MA.